🔎 Trials Near Me

Home › Acute Biphenotypic Leukemia › Illinois › Chicago

Acute Biphenotypic Leukemia clinical trials in Chicago, IL

7 studies for Acute Biphenotypic Leukemia are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RecruitingPhase 2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days · All sexes · Updated Sep 25, 2026 · NCT06317662

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
  • The University of Chicago Medical Center, Chicago
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RecruitingPhase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RecruitingPhase 3
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days – 25 Years · All sexes · Updated Aug 25, 2026 · NCT03959085

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RecruitingPhase 1/2
  • University of Illinois at Chicago Cancer Center, Chicago
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728

Venetoclax Basket Trial for High Risk Hematologic Malignancies

RecruitingPhase 1
  • Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Ages 1 to 40 · All sexes · Updated Mar 12, 2026 · NCT05292664

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Acute Biphenotypic Leukemia trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.